10-Q: THC Therapeutics Reports Q2 2024 Results: Focus Remains on dHydronator Development

THC Therapeutics, Inc. reports its financial results for the quarter ended January 31, 2024, highlighting ongoing efforts to develop its dHydronator product amid going concern uncertainties.

Summary

• THC Therapeutics, Inc. filed its Form 10-Q for the quarter ended January 31, 2024.
• The company is focused on developing its patented dHydronator, a sanitizing herb dryer.
• The dHydronator aims to reduce drying time for herbs, particularly cannabis, from 10-14 days to less than 14 hours.
• The company has a functioning prototype and plans to source parts for serial manufacturing and hire sales and marketing staff when funds are available.
• For the three months ended January 31, 2024, the company reported a net loss of $571,975, compared to a net income of $1,685,852 for the same period in 2023.
• For the six months ended January 31, 2024, the company reported a net loss of $634,460, compared to a net loss of $448,450 for the same period in 2023.
• As of January 31, 2024, the company had $3,511 in cash and an accumulated deficit of $39,058,405.
• The company's ability to continue as a going concern is dependent on generating revenues and raising capital.
• Management plans to use borrowings and security sales to mitigate cash flow deficits.
• The company settled a lawsuit with its former CEO for $100,000.
• The company also settled a dispute with Iliad Research and Trading, L.P.
• On March 13, 2024, the Company sold 56 shares of Series C Preferred Stock for $48,920, net of $5,080 in offering cost.
• On February 7, 2024, the Company issued 6,060,000 shares of common stock for $263,000 cash, all of which was received during the year ended July 31, 2022 and was included in stock payable as of year-end.

Sentiment

Score: 3

Explanation: The document presents a concerning financial situation with a high risk of the company not being able to continue as a going concern. The company's low cash position, accumulated deficit, and increased net loss contribute to the negative sentiment.

Positives

• The company is focused on developing a potentially innovative product, the dHydronator, which could disrupt the herb drying market.
• The company has secured a patent for the dHydronator.
• Operating losses decreased for the three months ended January 31, 2024, compared to the same period in the prior fiscal year.
• The company settled a lawsuit with its former CEO and a dispute with Iliad Research and Trading, L.P.

Negatives

• The company has a significant accumulated deficit of $39,058,405 as of January 31, 2024.
• The company's cash position is very low, with only $3,511 on hand as of January 31, 2024.
• The company has not generated sufficient revenues to finance its operations internally.
• The company's auditors have raised substantial doubt about its ability to continue as a going concern.
• Net loss increased for the six months ended January 31, 2024, compared to the same period in the prior fiscal year.
• Disclosure controls and procedures were not effective to provide reasonable assurance of achieving the objectives of timely alerting them to material information required to be included in our periodic SEC reports and of ensuring that such information is recorded, processed, summarized and reported with the time periods specified.

Risks

• The company's ability to continue as a going concern is highly uncertain and dependent on raising additional capital.
• The company faces competition from existing commercial herb dryers.
• The company's business plan is dependent on the successful development and commercialization of the dHydronator.
• The company may not be able to secure additional financing on acceptable terms or at all.
• The company's disclosure controls and procedures were not effective.

Future Outlook

The company intends to fund operations through sales of its herb dryer and debt and/or equity financing arrangements. The company plans to seek additional financing in a private equity offering to secure funding for operations.

Management Comments

• Management evaluated all relevant conditions and events that are reasonably known or reasonably knowable, in the aggregate, as of the date the consolidated financial statements are issued and determined that substantial doubt exists about the Company's ability to continue as a going concern.
• Management plans to use borrowings and security sales to mitigate the effects of cash flow deficits.

Industry Context

The company operates in the wellness industry, specifically targeting the cannabis and home herb and garden product markets with its dHydronator product. The company faces competition from existing commercial herb dryers.

Comparison to Industry Standards

• The document mentions Yofumo Technologies as a competitor with significant market share in commercial herb dryers.
• The dHydronator aims to reduce drying time for cannabis to less than 14 hours, compared to traditional methods that can take up to two weeks.
• The company's proprietary sanitizing technology aims to reduce the bacterial count of cannabis during the drying process.

Legal Proceedings

• In the spring of 2021, the Company's former CEO, Parker Mitchell, filed suit against the Company for wrongful termination, which was subsequently settled on or about December 12, 2021.
• On or about January 5, 2021, another Company lender, Iliad Research and Trading, L.P. (Iliad), sent a demand letter to the Company regarding the Company's alleged default under its promissory note issued to Iliad, which was subsequently settled on January 31, 2024.

Related Party Transactions

• Advances from related parties consist of $59,626 principal as of January 31, 2024, from B. Romanek, President and CEO.
• On May 1, 2019, the company entered into a convertible promissory note pursuant to which it borrowed $200,000 from Harvey Romanek, the father of the Company's Chief Executive Officer, Brandon Romanek.

Stakeholder Impact

• Shareholders face significant risk due to the company's going concern uncertainties.
• Employees' job security is uncertain due to the company's financial difficulties.
• Customers may be impacted by the company's ability to deliver its dHydronator product.
• Creditors face risk of non-payment due to the company's financial situation.

Next Steps

• The company plans to source parts for serial manufacturing of the dHydronator.
• The company plans to hire sales and marketing staff as funds are available.
• The company plans to seek additional financing in a private equity offering.
• The company intends to engage in further development efforts once it has at least $2,000,000 in available cash flow or funds from other operations and if it receives the patent.

Key Dates

Keywords

dHydronator, herb dryer, cannabis, THC Therapeutics, financial results, going concern, patent, sanitizing, drying